Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.96 |
| ▸ | PPARG | P37231 | 6/20 | 0.96 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.96 |
| ▸ | MAPT | P10636 | 5/20 | 0.96 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.96 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.96 |
| ▸ | RXRA | P19793 | 2/20 | 0.96 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.74 |
| ▸ | PPARA | Q07869 | 5/20 | 0.74 |
| ▸ | F7 | P08709 | 4/20 | 0.74 |
| ▸ | F3 | P13726 | 4/20 | 0.74 |
| ▸ | PPARD | Q03181 | 4/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.74 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.69 |
| ▸ | HPGD | P15428 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL276082 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL3221528 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL116899 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL117314 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL16269975 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL742417 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL16232222 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL742418 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL116898 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL3221804 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGCYP19A1MAPTFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 19498 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746844-A1 | PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122095450-A | Electrolytic capacitor | — | 2026-05-26 | — | — | CN | claimed |
| US-12637408-B2 | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-05-26 | — | — | US | claimed |
| EP-3956283-B1 | PROCESS OF PREPARING POLYOL-BASED ESTERS OF ACYL-CAPPED HYDROXY CARBOXYLIC ACIDS | KETOLIPIX THERAPEUTICS GMBH (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026102111-A1 | METHODS FOR TREATING OR PREVENTING PROSTATE CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260132353-A1 | LIPID COMPRISING DOCOSAPENTAENOIC | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-05-14 | — | — | US | claimed |
| US-20260115138-A1 | LIPID NANOPARTICLES | CODEBRIDGEBIO INC (US) | 2026-04-30 | — | — | US | claimed |
| EP-4733373-A1 | METHOD FOR PRODUCING HIGHLY UNSATURATED FATTY ACID ESTER COMPOSITION | Nissui Corporation (JP) | 2026-04-29 | — | — | EP | claimed |
| EP-3858152-B1 | METHOD FOR LONG-TERM STORAGE OF CHLOROPHYLL-CONTAINING EXTRACT | MYUNG EUN LEE (KR) | 2026-04-29 | — | — | EP | claimed |
| EP-3938339-B1 | METHODS OF OBTAINING LIPIDS FROM A MICROBIAL CELL COMPOSITION | DSM IP ASSETS BV (NL) | 2026-04-29 | — | — | EP | claimed |
| EP-0287198-B1 | MIXTURES OF POLAR AND NEUTRAL LIPIDS FOR PROTECTING THE GASTRONOINTESTINAL TRACT | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-04-15 | — | — | EP | claimed |
| EP-0460848-A1 | Stearidonic acid and/or eicosatetraenoic acid for the treatment of inflammations | EFAMOL HOLDINGS PLC (GB) | 1991-12-11 | — | — | EP | claimed |
| EP-0454102-A2 | Essential fatty acid compositions | EFAMOL HOLDINGS PLC (GB) | 1991-10-30 | — | — | EP | claimed |
| US-4977187-A | Administering effective amount of gamma linolenic acid, stearidonic acid and vitamin E | EFAMOL HOLDINGS PLC (GB) | 1990-12-11 | — | — | US | claimed |
| US-4950656-A | WITH TRIGLYCERIDES AND/OR STEROLS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1990-08-21 | — | — | US | claimed |
| US-4918063-A | PHOSPHOLIPID AND TRIGLYCERIDES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1990-04-17 | — | — | US | claimed |
| EP-0347056-A1 | Essential fatty acid compositions | SCOTIA HOLDINGS PLC (GB) | 1989-12-20 | — | — | EP | claimed |
| EP-0298644-A2 | Indium, caesium or cerium compounds for treatment of cerebral disorders | EFAMOL HOLDINGS PLC (GB) | 1989-01-11 | — | — | EP | claimed |
| US-4776984-A | TREATING WITH UREA; SOLVENT EXTRACTION; CAROMATOGRAPHY | NESTEC S. A. (CH) | 1988-10-11 | — | — | US | claimed |
| US-4758592-A | Method of treating or preventing endometriosis | EFAMOL LIMITED (GB) | 1988-07-19 | — | — | US | claimed |